Eyal C. Attar's Net Worth
$857 Thousand
Who is Eyal C. Attar?
Eyal C. Attar does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vor Biopharma Inc., and Aprea Therapeutics, Inc..
SEC CIK
Eyal C. Attar's CIK is 0001789076
Past Insider Trading and Trends
2019 was Eyal C. Attar's most active year for acquiring shares with 3 total transactions. Eyal C. Attar's most active month to acquire stocks was the month of January. 2023 was Eyal C. Attar's most active year for disposing of shares, totalling 3 transactions. Eyal C. Attar's most active month to dispose stocks was the month of July. 2019 saw Eyal C. Attar paying a total of $6,000.00 for 78,030 shares, this is the most they've acquired in one year. In 2021 Eyal C. Attar cashed out on 25,000 shares for a total of $110,677.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vor Biopharma Inc. (VOR) Snapshot price: $2.35
CHIEF MEDICAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.23% | -14.64K |
$1.39 | -$20,356.55 | 96.06K |
Scheduled
|
Jun 3
| ||
Form 4
| -0.89% | -1.00K |
$1.75 | -$1,748.25 | 110.71K |
May 6
| |||
Form 4
| -1.02% | -1.15K |
$1.77 | -$2,028.42 | 111.71K |
May 1
| |||
Form 4
| -1.03% | -1.18K |
$2.32 | -$2,737.60 | 112.85K |
Feb 6
| |||
Form 4
| +121.28% | 62.5K |
—
|
—
| 114.03K |
Jan 29
| |||
Form 4
| -1.90% | -1.00K |
$1.82 | -$1,818.18 | 51.53K |
Nov 6
| |||
Form 4
| -1.87% | -1.00K |
$2.67 | -$2,667.33 | 52.53K |
Aug 7
| |||
Form 4
| -1.78% | -969.00 |
$4.14 | -$4,011.66 | 53.53K |
May 8
| |||
Form 4
|
∞
| 54.5K |
—
|
—
| 54.5K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aprea Therapeutics, Inc. (APRE) Snapshot price: $6.713
SVP, Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -36.34% | -32.67K |
$0.81 | -$26,296.93 | 57.23K |
Jun 3
| |||
Form 4
| +91.28% | 42.9K |
—
|
—
| 89.9K |
Mar 10
| |||
Form 4
| -43.37% | -36.00K |
$1.73 | -$62,280.00 | 47K |
Scheduled
|
Feb 28
| ||
Form 4
| -16.13% | -15.97K |
$4.68 | -$74,730.24 | 83K |
Scheduled
|
Sep 16
| ||
Form 4
| -8.36% | -9.03K |
$3.98 | -$35,947.36 | 98.97K |
Aug 25
| |||
Form 4
|
∞
| 108K |
—
|
—
| 108K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 4
|
∞
| 400 |
$15.00 | $6,000.00 | 400 |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||